Background: In the present study, autophagy-related long non-coding RNAs (lncRNAs) in lung adenocarcinoma (LUAD) were screened for diagnosis and prognosis, and the molecular mechanisms of LUAD at the genetic level were investigated. Methods: From The Cancer Genome Atlas (TCGA) database, 497 gene expression data and 436 clinical data of LUAD cases were collected for analysis. In addition, 232 autophagy-related genes (ARGs) were extracted from the Human Autophagy Database (HADb). Spearman rank correlation test and the Akaike information criterion (AIC) were performed to screen the data. After filtering, a survival model including three autophagy-related lncRNAs was generated. Based on the following formula: risk score = ΣCoef gene i×Gene i expression, the risk score of all LUAD patients could be calculated. LUAD patients were divided into two groups based on risk score for survival curve using Kaplan-Meier survival analysis. Both univariate and multivariate survival analyses were used to determine whether the three lncRNAs were independent prognostic factors using the survival package in R. Furthermore, the receiver operating characteristic (ROC) curves of clinical data were created to assess the stability of the survival model. Finally, the Gene Set Enrichment Analysis (GSEA) was used for analysis of related pathways. Results: A prognostic model consisting of three lncRNAs (AC011477.2, AC099850.3, and TRG-AS1) was generated for analysis. The 5-year survival rate in the high-risk group was 26.51% (95% CI: 0.1842 - 0.382), which was statistically lower than in the low-risk group 41.6% (95% CI: 0.307 - 0.563, P < 0.05). The area under the ROC curve (AUC) of risk score was 0.700, indicating a higher diagnostic accuracy of risk score. The results of GSEA showed enrichment in 36 pathways, including pyrimidine metabolism, pentose phosphate pathway, citric acid cycle, and cell cycle in the high-risk group, and FC-EPSILON-RI signal pathway, intestinal immune network produced by IgA, and ABC transporters in the low-risk group. Conclusion: The prognosis model composed of autophagy-related lncRNAs, AC011477.2, AC099850.3, and TRG-AS1, in LUAD can be used to predict the prognosis of LUAD patients and is expected to improve clinical treatment.
References
[1]
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
[2]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[3]
Sun, R., Liu, Z., Wang, L., Lv, W., Liu, J., Ding, C., et al. (2015) Overexpression of Stathmin Is Resistant to Paclitaxel Treatment in Patients with Non-Small Cell Lung Cancer. Tumor Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 36, 7195-7204. https://doi.org/10.1007/s13277-015-3361-y
[4]
Liu, G., Pei, F., Yang, F., Li, L., Amin, A. D., Liu, S., et al. (2017) Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences, 18, 367. https://doi.org/10.3390/ijms18020367
[5]
Zhu, Y., Wang, R., Chen, W., Chen, Q. and Zhou, J. (2020) Construction of a Prognosis-Predicting Model Based on Autophagy-Related Genes for Hepatocellular Carcinoma (HCC) Patients. Aging, 12, 14582-14592. https://doi.org/10.18632/aging.103507
[6]
Kopp, F. and Mendell, J.T. (2018) Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell, 172, 393-407. https://doi.org/10.1016/j.cell.2018.01.011
[7]
Tian, F., Wang, J., Zhang, Z. and Yang, J. (2020) LncRNA SNHG7/miR-34a-5p/SYVN1 Axis Plays a Vital Role in Proliferation, Apoptosis and Autophagy in Osteoarthritis. Biological Research, 53, 9. https://doi.org/10.1186/s40659-020-00275-6
[8]
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., et al. (2017) Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170, 548-563.e16. https://doi.org/10.1016/j.cell.2017.07.008
[9]
Zhang, W., Yuan, W., Song, J., Wang, S. and Gu, X. (2018) LncRNA CPS1-IT1 Suppresses EMT and Metastasis of Colorectal Cancer by Inhibiting Hypoxia-Induced Autophagy through Inactivation of HIF-1α. Biochimie, 144, 21-27. https://doi.org/10.1016/j.biochi.2017.10.002
[10]
Wu, L., Wen, Z., Song, Y. and Wang, L. (2021) A Novel Autophagy-Related lncRNA Survival Model for Lung Adenocarcinoma. Journal of Cellular and Molecular Medicine, 25, 5681-5690. https://doi.org/10.1111/jcmm.16582
[11]
Chen, C., Huang, H. and Wu, C.H. (2017) Protein Bioinformatics Databases and Resources. Methods in Molecular Biology (Clifton, N.J.), 1558, 3-39. https://doi.org/10.1007/978-1-4939-6783-4_1
[12]
Angarica, V.E. and Del Sol, A. (2017) Bioinformatics Tools for Genome-Wide Epigenetic Research. Advances in Experimental Medicine and Biology, 978, 489-512. https://doi.org/10.1007/978-3-319-53889-1_25
[13]
Chang, C.P., Su, Y.C., Lee, P.H. and Lei, H.Y. (2013) Targeting NFKB by Autophagy to Polarize Hepatoma-Associated Macrophage Differentiation. Autophagy, 9, 619-621. https://doi.org/10.4161/auto.23546
[14]
Ichimura, Y., Waguri, S., Sou, Y.S., Kageyama, S., Hasegawa, J., Ishimura, R., et al. (2013) Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy. Molecular Cell, 51, 618-631. https://doi.org/10.1016/j.molcel.2013.08.003
[15]
Zhou, Y., Sun, K., Ma, Y., Yang, H., Zhang, Y., Kong, X., et al. (2014) Autophagy Inhibits Chemotherapy-Induced Apoptosis through Downregulating Bad and Bim in Hepatocellular Carcinoma Cells. Scientific Reports, 4, Article No. 5382. https://doi.org/10.1038/srep05382
[16]
Zhang, P., Pan, Y., Sun, J. and Pan, G. (2021) Aberrant Expression of LncRNA CASC2 Mediated the Cell Viability, Apoptosis and Autophagy of Colon Cancer Cells by Sponging miR-19a via NF-κB Signaling Pathway. International Journal of Experimental Pathology, 102, 163-171. https://doi.org/10.1111/iep.12393
[17]
Wang, Y., Lin, C. and Liu, Y. (2021) Molecular Mechanism of miR-34b-5p and RNA Binding Protein HuR Binding to lncRNA OIP5-AS1 in Colon Cancer Cells. Cancer Gene Therapy. https://doi.org/10.1038/s41417-021-00342-4
[18]
Wang, Z. (2021) LncRNA CCAT1 Downregulation Increases the Radiosensitivity of Non-Small Cell Lung Cancer Cells. The Kaohsiung Journal of Medical Sciences, 37, 654-663. https://doi.org/10.1002/kjm2.12387
[19]
Liang, Y., Song, X., Li, Y., Chen, B., Zhao, W., Wang, L., et al. (2020) LncRNA BCRT1 Promotes Breast Cancer Progression by Targeting miR-1303/PTBP3 Axis. Molecular Cancer, 19, 85. https://doi.org/10.1186/s12943-020-01206-5
[20]
Wu, F., Wei, H., Liu, G. and Zhang, Y. (2021) Bioinformatics Profiling of Five Immune-Related lncRNAs for a Prognostic Model of Hepatocellular Carcinoma. Frontiers in Oncology, 11, Article ID: 667904. https://doi.org/10.3389/fonc.2021.667904
[21]
Zhou, R.S., Zhang, E.X., Sun, Q.F., Ye, Z.J., Liu, J.W., Zhou, D.H., et al. (2019) Integrated Analysis of lncRNA-miRNA-mRNA ceRNA Network in Squamous Cell Carcinoma of Tongue. BMC Cancer, 19, 779. https://doi.org/10.1186/s12885-019-5983-8
[22]
He, S., Wang, X., Zhang, J., Zhou, F., Li, L. and Han, X. (2020) TRG-AS1 Is a Potent Driver of Oncogenicity of Tongue Squamous Cell Carcinoma through microRNA-543/Yes-Associated Protein 1 Axis Regulation. Cell Cycle (Georgetown, Tex.), 19, 1969-1982. https://doi.org/10.1080/15384101.2020.1786622
[23]
Sun, X., Qian, Y., Wang, X., Cao, R., Zhang, J., Chen, W., et al. (2020) LncRNA TRG-AS1 Stimulates Hepatocellular Carcinoma Progression by Sponging miR-4500 to Modulate BACH1. Cancer Cell International, 20, 367. https://doi.org/10.1186/s12935-020-01440-3
[24]
Xie, H., Shi, S., Chen, Q. and Chen, Z. (2019) LncRNA TRG-AS1 Promotes Glioblastoma Cell Proliferation by Competitively Binding with miR-877-5p to Regulate SUZ12 Expression. Pathology, Research and Practice, 215, Article ID: 152476. https://doi.org/10.1016/j.prp.2019.152476
